- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06689800
Seamos REALES: Herramienta de comunicación sobre salud familiar en trasplantes de células madre y terapia celular pediátricos
Seamos REALES: una prueba piloto de una herramienta de comunicación sobre la salud familiar en el trasplante de células madre y la terapia celular pediátricos
The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Ginny L Schulz, Ph.D., RN, CPNP-PC
- Número de teléfono: 314-454-6018
- Correo electrónico: schulz_g@wustl.edu
Ubicaciones de estudio
-
-
Missouri
-
St Louis, Missouri, Estados Unidos, 63110
- Reclutamiento
- Washington University School of Medicine
-
Sub-Investigador:
- Shalini Shenoy, M.D.
-
Contacto:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
- Número de teléfono: 314-454-6018
- Correo electrónico: schulz_g@wustl.edu
-
Investigador principal:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
-
Sub-Investigador:
- Amy McQueen, Ph.D.
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria Youth:
- Children or adolescents 8-17 years of age referred for SCTCT.
- Diagnosis of malignant or nonmalignant disorder.
- Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
- Planning to meet with a provider to discuss SCTCT.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
- Must speak English and be cognitively able to participate.
Inclusion Criteria Parents:
- Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
- Must speak English and be cognitively able to participate.
Exclusion Criteria Youth:
-
Active medical problems severe enough to preclude study participation at the time of recruitment.
- Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
-
Lacks cognitive capacity to complete study activities, as determined by consenting professional.
Exclusion Criteria Parents:
- Their youth referred for SCTCT does not assent to participate.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Let's Get REAL family health communication tool: Patients (8-12 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Experimental: Let's Get REAL family health communication tool: Patients (13-17 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Experimental: Let's Get REAL family health communication tool: Parents
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Feasibility of intervention as measured by the Feasibility of Intervention questionnaire
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Acceptability of intervention as measured by the Acceptability of Intervention questionnaire
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Feasibility of intervention as measured qualitatively
Periodo de tiempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of feasibility content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Acceptability of intervention as measured qualitatively
Periodo de tiempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of acceptability content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Appropriateness of intervention as measured qualitatively
Periodo de tiempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of appropriateness content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Número de pacientes que eligieron SCTCT
Periodo de tiempo: Hasta 4 semanas después de la consulta SCTCT (se estima que es la semana 8)
|
Hasta 4 semanas después de la consulta SCTCT (se estima que es la semana 8)
|
|
|
Difference in feasibility scores in those 8-12 years of age and those 13-17 years of age as measured by the Feasibility of Intervention questionnaire
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in acceptability scores in those 8-12 years of age and those 13-17 years of age as measured by the Acceptability of Intervention questionnaire
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in appropriateness scores in those 8-12 years of age and those 13-17 years of age as measured by the Intervention of Appropriateness questionnaire
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Perceived levels of decision-making involvement in youth 8-17 years of age and their parents as measured by the Decision Making Involvement Scale
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 30-item scale that youth and their parents report youth involvement behaviors in a decision related to their illness on a 4-point Likert scale ranging from 'A Little Bit' to 'A Lot'. The higher the subscale score (child seek, child express, parent seek, parent express, and joint/options), the more that behavior or type of involvement occurred in the decision making process. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Observed levels of decision-making involvement in youth 8-17 years of age and their parents
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of utterance occurrences for the following: 1) who uttered (youth, parent), 2) was utterance prompted (yes/no), if so, by who, 3) type of utterance (questions, opinion, concern, other), and 4) content of utterance (prognosis, side effect, expectation). |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Change in youth-parent communication as measured by the Likert-type Parent-Adolescent Communication Scale
Periodo de tiempo: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is a 20-item scale that youth and parents report the degree of openness in family communication and the extent of problems with family communications on a 5-point Likert ranging from 'strongly disagree' to 'strongly agree'. A higher score on the degree of openness subscale indicates better communication between parent and adolescent. For extent of problems subscale, a higher score indicates more problems in the parent-child communication. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Change in the level of youth's general anxiety as measured by the Likert-type PROMIS Anxiety 8a Short Form or parent proxy
Periodo de tiempo: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is an 8-item scale that measures youth's general anxiety in those 8-17 years of age on a 5-point Likert scale ranging from 'never' to 'almost always'. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Level of decisional conflict as measured by the Likert-type Decisional Conflict Scale
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 10-item scale that youth and parents report their personal uncertainty and decisional conflict related to a specific decision. We are using the question format as it is recommended for those with limited reading or response skills. They respond 'Yes', 'No, or 'Unsure'. A total decision conflict score ranges from 0 (no decisional conflict) to 100 (extremely high decision conflict). Higher scores on subscales uncertainty, informed, values clarity, and support reflect feeling extremely uncertain about the best choice, feeling extremely uninformed, feeling extremely unclear about personal values, and feeling extremely unsupported in decision making respectively. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Youth-parent congruence of youth decision making involvement as measured by two Likert type statements
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of dyads that agree on these two statements measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot': 1)"I/my child should be involved in future talks about transplant" and 2) "I/my child wants to be involved in future talks about transplant". |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Satisfaction with the decision making involvement as measured by one Likert type statement
Periodo de tiempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a one item statement, "I am satisfied with my/my child's involvement in the transplant decision making process", measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot'. A higher score indicates more satisfaction. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Trastornos de insuficiencia de la médula ósea
- Neoplasias por sitio
- Neoplasias
- Enfermedades Genéticas Congénitas
- Enfermedades del sistema inmunológico
- Enfermedades hematológicas
- Enfermedades de la médula ósea
- Anemia Hemolítica Congénita
- Anemia Hemolítica
- Anemia
- Hemoglobinopatías
- Enfermedades y anomalías congénitas, hereditarias y neonatales
- Enfermedades Nutricionales y Metabólicas
- Enfermedades hemic y linfáticas
- Neoplasias Hematológicas
- Anemia de células falciformes
- Síndromes de deficiencia inmunológica
- Enfermedades metabólicas
- Anemia Aplásica
Otros números de identificación del estudio
- 202410119
- K12CA167540 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .